Saag MS - Search Results

1

Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012.

Saag MS, Westfall AO, Cole SR, Mathews WC, Drozd DR, Mayer KH, Burkholder GA, Kitahata M, Maiese EM; CFAR Network of Integrated Clinical Systems (CNICS). Saag MS, et al. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):60-64. doi: 10.1097/QAI.0000000000001168. J Acquir Immune Defic Syndr. 2017. PMID: 27552153 Free PMC article.

2

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al. Kappes JC, et al. Among authors: saag ms. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49. doi: 10.1097/00042560-199510020-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552477 Clinical Trial.

3

Pathogenicity and diversity of HIV and implications for clinical management: a review.

Saag MS, Hammer SM, Lange JM. Saag MS, et al. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 2:S2-10; discussion S10-1. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7965648 Review.

4

Issues in combination antiretroviral therapy: a review.

Hammer SM, Kessler HA, Saag MS. Hammer SM, et al. Among authors: saag ms. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 2:S24-35; discussion S35-7. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7965649 Review.

5

Use of virologic markers in clinical practice.

Saag MS. Saag MS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S3-13. doi: 10.1097/00042560-199701001-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9389310 Review.

6

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

7

Health-related quality of life and virologic outcomes in an HIV clinic.

Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Call SA, et al. Among authors: saag ms. Qual Life Res. 2000;9(9):977-85. doi: 10.1023/a:1016668802328. Qual Life Res. 2000. PMID: 11332226

8

Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.

Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS. Chen RY, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):909-16. doi: 10.1089/088922202760265588. AIDS Res Hum Retroviruses. 2002. PMID: 12230934

9

Patient-perceived barriers to antiretroviral adherence: associations with race.

Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS. Ferguson TF, et al. Among authors: saag ms. AIDS Care. 2002 Oct;14(5):607-17. doi: 10.1080/0954012021000005434. AIDS Care. 2002. PMID: 12419110

10

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS; International AIDS Society-USA. Schambelan M, et al. Among authors: saag ms. J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):257-75. doi: 10.1097/00126334-200211010-00001. J Acquir Immune Defic Syndr. 2002. PMID: 12439201 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page